{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/irritable-bowel-syndrome/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"fbcab9c4-bcb5-5d61-855f-1ec3aef8fdfe","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 5fc050bb-25c0-4012-adbc-fc8fc372600e --><h2>Update</h2><!-- end field 5fc050bb-25c0-4012-adbc-fc8fc372600e -->","summary":null,"htmlStringContent":"<!-- begin item 46236e5c-fa8e-4baa-a397-372547a3b27e --><!-- end item 46236e5c-fa8e-4baa-a397-372547a3b27e -->","topic":{"id":"4bb8acbd-d2b1-5f93-9ffa-0a3f11076292","topicId":"2c2fedc7-3daf-462e-b168-78c86cb2a2ec","topicName":"Irritable bowel syndrome","slug":"irritable-bowel-syndrome","lastRevised":"Last revised in October 2020","chapters":[{"id":"e08d84ab-7283-58cb-9873-bebac62d6494","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"09b06ced-d018-5c24-883c-ff37be197b2d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"14d879ef-e87a-571a-a829-4f236e5265b8","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0858c465-429d-5390-b8bd-432cb1d0fb46","slug":"changes","fullItemName":"Changes"},{"id":"fbcab9c4-bcb5-5d61-855f-1ec3aef8fdfe","slug":"update","fullItemName":"Update"}]},{"id":"d1d333cb-5ad0-5c55-987c-0d9bcdd7219b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"df8485dd-d258-554e-91a1-cfae144c8f3a","slug":"goals","fullItemName":"Goals"},{"id":"92f70986-7a29-5aaf-8c2b-e24b675e84dc","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4cbbe159-85f5-573d-a6f1-cf83b24c7513","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b054d7f7-3303-57ad-bc98-df229e629e9c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d5eb318d-cbd0-556b-8ce7-6c20aab02bc0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c7ecf3c9-b183-5b40-99b8-9fa4ac12bfb8","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"156f0f16-df4f-5fcf-94da-2e9dfe0d9ae7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d091ffcd-a585-5def-b8a6-6a8e82be964d","slug":"definition","fullItemName":"Definition"},{"id":"08e0e6c7-a53c-53d9-a8ff-37b9af0475a9","slug":"causes","fullItemName":"Causes"},{"id":"2af080fe-338c-5682-927e-df91b2056310","slug":"prevalence","fullItemName":"Prevalence"},{"id":"668a8344-5367-57b6-be24-4904a8b84c09","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"d71af51f-0d21-583c-ae74-cdeefe5efe9a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1e13d165-63d9-5000-8411-3cb047828b3a","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d335e933-3ba3-56d3-9f86-ccb100e2cb09","slug":"assessment","fullItemName":"Assessment"},{"id":"f6a63ea2-fb31-5f4c-b6ca-21ee922d5615","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a0f45b9c-efa3-5c88-a5bc-3cd26c71883f","fullItemName":"Management","slug":"management","subChapters":[{"id":"d4748fe8-65f9-5b0b-bbd0-32469fde1c78","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"86d862ff-43f3-59ac-9769-c4bc0ec5ea9b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4517eb7c-ad75-5732-86b2-ea7cf18e7a93","slug":"bulk-forming-laxatives","fullItemName":"Bulk-forming laxatives"},{"id":"712646a9-5a89-5454-b98e-b2d2dce9ac3d","slug":"linaclotide","fullItemName":"Linaclotide"},{"id":"b36ea15d-0d7e-5080-9c77-f7f1b274523b","slug":"loperamide","fullItemName":"Loperamide"},{"id":"c7ea4d4a-3d5a-5cdb-8999-e01670699563","slug":"antispasmodic-drugs","fullItemName":"Antispasmodic drugs"},{"id":"b5eff265-676e-584f-a5d6-0a4714238d8f","slug":"antidepressant-drugs","fullItemName":"Antidepressant drugs"}]},{"id":"2c06aa30-84a6-5e94-8d6f-1d960d28dcdc","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"25c14e40-3957-5b26-aa34-0afc73225fdd","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"38e74c6b-daec-50bd-a23a-3aa30b83db82","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c6497438-25eb-590a-9d9d-dfe08a17fb21","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"36885cba-cf5e-5cab-a474-2c0fc504fa91","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"89b5e4f9-0ed1-5b13-8258-3ba2b6f5b43e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d3199940-6be9-57b4-a2b0-2ee240db6d97","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5667ce2f-151b-57f5-9fde-07b6339b1aef","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"14d879ef-e87a-571a-a829-4f236e5265b8","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"33ce24d2-39d2-5c98-9415-41e156dab100","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field cd50c7ec-84a4-4c3a-ac33-8c9851efb9bf --><h3>New evidence</h3><!-- end field cd50c7ec-84a4-4c3a-ac33-8c9851efb9bf -->","summary":null,"htmlStringContent":"<!-- begin item 7d790051-878f-4cf6-98ee-a9b3d736bbcb --><!-- begin field 8697ec8d-106c-4730-86cf-700149bffd66 --><h3>Evidence-based guidelines</h3><!-- end field 8697ec8d-106c-4730-86cf-700149bffd66 --><!-- begin field d1c64b7d-6afc-4430-98c6-210a70c7b9df --><p>No new evidence-based guidelines published since September 2017.</p><!-- end field d1c64b7d-6afc-4430-98c6-210a70c7b9df --><!-- begin field 7f071f12-a063-499e-8ac0-5d62485cb86b --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 7f071f12-a063-499e-8ac0-5d62485cb86b --><!-- begin field 0b4c16ea-2b72-4967-b71f-e7ee8e5c1dae --><p>No new HTAs since 1 September 2017.</p><!-- end field 0b4c16ea-2b72-4967-b71f-e7ee8e5c1dae --><!-- begin field 630d1675-297f-4b19-9d6e-e8e7777b6d0d --><h3>Economic appraisals</h3><!-- end field 630d1675-297f-4b19-9d6e-e8e7777b6d0d --><!-- begin field f3fcab65-382e-4705-8d44-cdb677003f14 --><p>No new economic appraisals relevant to England since 1 September 2017.</p><!-- end field f3fcab65-382e-4705-8d44-cdb677003f14 --><!-- begin field 896cabb2-37d4-4f95-990c-085b4e3b61aa --><h3>Systematic reviews and meta-analyses</h3><!-- end field 896cabb2-37d4-4f95-990c-085b4e3b61aa --><!-- begin field 12cccbdd-7bb9-4a3e-a117-d314f90cd61e --><ul><li>NIHR Signal (2019) <em>Treatments for depression may help irritable bowel symptoms. </em>NIHR Signal. <a href=\"https://discover.dc.nihr.ac.uk/portal/home\" data-hyperlink-id=\"1b7ea61b-f64c-40b4-82d7-a9fc00e8a040\">www.discover.nihr.ac.uk</a> [<a href=\"https://discover.dc.nihr.ac.uk/content/signal-000732/irritable-bowel-may-be-helped-by-depresssion-treatments\" data-hyperlink-id=\"781aabda-df5b-4c9b-a1be-a9fc00e8a07c\">Free Full-text</a>]</li></ul><!-- end field 12cccbdd-7bb9-4a3e-a117-d314f90cd61e --><!-- begin field 5daa387f-757c-468d-9e56-90c36d0818c7 --><h3>Primary evidence</h3><!-- end field 5daa387f-757c-468d-9e56-90c36d0818c7 --><!-- begin field dadab5e6-3a96-4c32-9fc1-21389d7ef627 --><p>No new randomized controlled trials published since 1 September 2017.</p><!-- end field dadab5e6-3a96-4c32-9fc1-21389d7ef627 --><!-- end item 7d790051-878f-4cf6-98ee-a9b3d736bbcb -->","subChapters":[]},{"id":"15b51aef-3d7b-5041-91e7-be099f52f949","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 561a573b-9f4a-4b24-b4ff-db53d99111f4 --><h3>New policies</h3><!-- end field 561a573b-9f4a-4b24-b4ff-db53d99111f4 -->","summary":null,"htmlStringContent":"<!-- begin item 7ba3cd43-d5a9-475f-8bf6-e01750b2abe8 --><!-- begin field 46e63778-a4ae-4891-b2e7-43cee1af35a0 --><p>No new national policies or guidelines since 1 September 2017.</p><!-- end field 46e63778-a4ae-4891-b2e7-43cee1af35a0 --><!-- end item 7ba3cd43-d5a9-475f-8bf6-e01750b2abe8 -->","subChapters":[]},{"id":"4c24c35d-9200-5781-89a3-47189a24012b","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 018baeb6-18eb-48af-b7ad-627ec9ba1db1 --><h3>New safety alerts</h3><!-- end field 018baeb6-18eb-48af-b7ad-627ec9ba1db1 -->","summary":null,"htmlStringContent":"<!-- begin item 570c699f-65a8-4c48-b117-e99918bf4ca2 --><!-- begin field 95058867-4345-4c12-b647-4d5c290e5236 --><p>No new safety alerts since 1 September 2017.</p><!-- end field 95058867-4345-4c12-b647-4d5c290e5236 --><!-- end item 570c699f-65a8-4c48-b117-e99918bf4ca2 -->","subChapters":[]},{"id":"75110a37-d2fc-55d5-a94c-51a49b47a278","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 0a6a7748-9fac-49a6-89d4-918feb71bd80 --><h3>Changes in product availability</h3><!-- end field 0a6a7748-9fac-49a6-89d4-918feb71bd80 -->","summary":null,"htmlStringContent":"<!-- begin item 8aaa0fd2-f42c-42af-91bc-9aac4248ae43 --><!-- begin field cc3fd5ed-04b5-400b-892e-a9ede86961d7 --><ul><li>Buscomint peppermint oil 0.2 ml gastro-resistant capsule is licensed for use in patients aged ≥12 years and who weigh at least 40 kg, for the symptomatic relief of abdominal pain, minor spasms of the gastrointestinal tract, and flatulence, especially in patients with irritable bowel disease. See more <a href=\"https://www.medicines.org.uk/emc/product/11329/smpc\" data-hyperlink-id=\"d35830dd-dd4a-4879-a9e9-abbc0097c11a\">here</a>.</li></ul><!-- end field cc3fd5ed-04b5-400b-892e-a9ede86961d7 --><!-- end item 8aaa0fd2-f42c-42af-91bc-9aac4248ae43 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}